High Levels of Physical Activity Reduce the Esthetic Durability of Botulinum Toxin Type A: A Controlled Single-Blind Clinical Trial
- PMID: 37505732
- PMCID: PMC10467136
- DOI: 10.3390/toxins15070463
High Levels of Physical Activity Reduce the Esthetic Durability of Botulinum Toxin Type A: A Controlled Single-Blind Clinical Trial
Abstract
The present study aimed to evaluate the influence of physical activity on the durability of the esthetic effect of botulinum toxin type A (BoNT-A). Sixty female patients were allocated to three groups (n = 20) according to their physical activity level (PA): Low PA, Moderate PA, and High PA. All groups received a single injection of onabotulinumtoxinA, considering standardized doses in the frontalis (12U), corrugator supercilia (7U, each), and procerus muscles (4U). Outcomes were measured using electromyography (EMG), Merz 5-point scales, and Face-Q scales (perceived age and lines between eyebrows). A follow-up occurred after 30, 60, and 90 days. EMG results showed a significant decrease in muscle activity in the Low-PA group at all follow-ups compared with the other groups (p < 0.001). The Merz scale scores showed that the severity of forehead and glabellar lines significantly improved in the Low-PA group throughout this study compared with the other groups (p < 0.001). No significant differences between groups were found in the Face-Q scale for perceived age, while the Face-Q scale for lines between eyebrows showed better results for Low-PA (p < 0.01) and Moderate-PA (p < 0.01) groups compared to the High-PA group at the 30- and 90-day follow-ups. The durability of the esthetic effect of BoNT-A seems to be negatively influenced by the level of physical activity.
Keywords: botulinum toxin; electromyography; physical activity; wrinkles.
Conflict of interest statement
The funding sources were not involved in the study design, collection, analysis, and interpretation of data, the decision to publish, or the preparation of the manuscript. The authors declare no conflict of interest.
Figures
Similar articles
-
Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.Arch Otolaryngol Head Neck Surg. 1997 Mar;123(3):321-6. doi: 10.1001/archotol.1997.01900030103013. Arch Otolaryngol Head Neck Surg. 1997. PMID: 9076240
-
Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.J Cosmet Dermatol. 2012 Dec;11(4):267-71. doi: 10.1111/jocd.12001. Epub 2012 Oct 2. J Cosmet Dermatol. 2012. PMID: 23174049 Clinical Trial.
-
A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.Dermatol Surg. 2009 Mar;35(3):429-35; discussion 435-6. doi: 10.1111/j.1524-4725.2009.01063.x. Epub 2009 Feb 22. Dermatol Surg. 2009. PMID: 19250310 Clinical Trial.
-
Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines.Toxins (Basel). 2022 Apr 10;14(4):268. doi: 10.3390/toxins14040268. Toxins (Basel). 2022. PMID: 35448877 Free PMC article. Review.
-
The cosmetic use of botulinum toxin type B in the upper face.Clin Dermatol. 2004 Jan-Feb;22(1):29-33. doi: 10.1016/j.clindermatol.2003.12.033. Clin Dermatol. 2004. PMID: 15158542 Review.
References
-
- Cotofana S., Fratila A.A., Schenck T.L., Redka-Swoboda W., Zilinsky I., Pavicic T. The Anatomy of the Aging Face: A Review. Facial Plast. Surg. 2016;32:253–260. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical